Medicare & Medicaid Restructuring Discussion with OECD Health Indicators

Summary

Medicare & Medicaid Restructuring Discussion with OECD Health Indicators The document provides statistical health data and generic policy discussion without mentioning any specific officials, financial transactions, or misconduct. It lacks actionable leads, controversial claims, or novel revelations linking powerful actors. Key insights: US ranks poorly on obesity, infant mortality, and medical resource metrics compared to OECD averages.; Comparative effectiveness research is highlighted as a tool for improving healthcare spending.; Medicare is legally barred from considering costs in coverage decisions.